These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3914976)

  • 1. [Bacteriostatic activity and salivary and blood protein interactions of midecamycin, a macrolide of dental importance].
    Pase U; Ceretti G; Perissinotto C
    G Stomatol Ortognatodonzia; 1985; 4(2):56-8. PubMed ID: 3914976
    [No Abstract]   [Full Text] [Related]  

  • 2. [Interaction between josamycin (Iosalide R.) and salivary and plasma proteins].
    Pase U; Miotti F; Miotti A; Bagolan A; Fusetti F
    G Stomatol Ortognatodonzia; 1984; 3(2):250-1. PubMed ID: 6084644
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative in vitro activity, serum binding and binding activity interactions of the macrolides A-56268, RU-28965, erythromycin and josamycin.
    Dette GA; Knothe H; Koulen G
    Drugs Exp Clin Res; 1987; 13(9):567-76. PubMed ID: 2962847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interaction of suprofen with salivary and blood proteins].
    Pase U; Dalla Venezia S; Magri C; Snichelotto G
    G Stomatol Ortognatodonzia; 1985; 4(2):45-6. PubMed ID: 3869588
    [No Abstract]   [Full Text] [Related]  

  • 5. Properties of midecamycin, a new macrolide antibiotic.
    Salhi A; Vindel JA; Brunaud M; Berceaux G; Marin A; Wuatelet C
    G Ital Chemioter; 1977; 24(1-2):67-76. PubMed ID: 308022
    [No Abstract]   [Full Text] [Related]  

  • 6. [Influence of a new macrolide, midecamycin on theophylline pharmacokinetics (author's transl)].
    Lavarenne J; Paire M; Talon O
    Therapie; 1981; 36(4):451-6. PubMed ID: 7292428
    [No Abstract]   [Full Text] [Related]  

  • 7. Bacteriological evaluation of midecamycin acetate and its metabolites.
    Yoshida T; Watanabe T; Shomura T; Someya S; Okamoto R; Ishihara S; Miyauchi K; Kazuno Y
    Jpn J Antibiot; 1982 Jun; 35(6):1462-74. PubMed ID: 6982352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of midecamycin acetate, a new macrolide antibiotic, on bactericidal action of human polymorphonuclear leukocytes.
    Nishimura T; Tabuki K
    J Chemother; 1989 Jul; 1(4 Suppl):427-8. PubMed ID: 16312471
    [No Abstract]   [Full Text] [Related]  

  • 9. [Passage of rovamycin (spiramycin) across the hematoencephalic barrier].
    Curci G; Ninni A; Vitale L
    G Ital Chemioter; 1972 Jul; 19(3):52-3. PubMed ID: 4671345
    [No Abstract]   [Full Text] [Related]  

  • 10. [Concentration of antibiotics in various jaw tissues: concentration of spiramycin. IV].
    Pignanelli M; Badile S; Tassarotti B; Cruciani S; Scaglione F; Fraschini F
    Dent Cadmos; 1983 Jun; 51(6):73-7. PubMed ID: 6583097
    [No Abstract]   [Full Text] [Related]  

  • 11. [Concentration of antibiotics in various jaw tissues: concentration of josamycin (3)].
    Pignanelli M; Berneri F; Santoro F; Scaglione F; Fraschini F
    Dent Cadmos; 1982 Mar; 50(3):25-30. PubMed ID: 6959862
    [No Abstract]   [Full Text] [Related]  

  • 12. [Annual changes in susceptibility of clinical isolates to midecamycin acetate].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukushima Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Sato K
    Jpn J Antibiot; 1990 Aug; 43(8):1341-52. PubMed ID: 2283704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Basic study and clinical application of acetyl-spiramycin in surgical field].
    Shibata K; Kuno K; Imazu I; Ito T; Inugai A
    J Antibiot B; 1966 Jun; 19(3):200-5. PubMed ID: 5298422
    [No Abstract]   [Full Text] [Related]  

  • 14. [Bacteriostatic effect of tetracyclines-macrolides associations].
    de Lajudie P
    Pathol Biol (Paris); 1971; 19(11):607-12. PubMed ID: 4397549
    [No Abstract]   [Full Text] [Related]  

  • 15. Cross resistance of Escherichia coli B. ribosomes to inhibition of the puromycin reaction by erythromycin, spiramycin and chloramphenicol.
    Rychlík I; Cerná J
    Hoppe Seylers Z Physiol Chem; 1968 Aug; 349(8):958-9. PubMed ID: 4878426
    [No Abstract]   [Full Text] [Related]  

  • 16. The in vitro activity of Midecamycin against various Vibrio species.
    Bonang G; Surjawidjaja JE; Santoso US
    Jpn J Exp Med; 1975 Feb; 45(1):43-5. PubMed ID: 1228226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The binding of blood plasma proteins and salivary proteins to hydroxyapatite columns and its effect on demineralization in an in vitro system].
    Krause S; Lösche W; Thielmann K
    Z Med Lab Diagn; 1989; 30(2):95-103. PubMed ID: 2711740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug interaction between midecamycin and cyclosporin.
    Finielz P; Mondon JM; Chuet C; Guiserix J
    Nephron; 1995; 70(1):136. PubMed ID: 7617108
    [No Abstract]   [Full Text] [Related]  

  • 19. [Protein binding of the macrolide antibiotic turimycin. Methodologic effects on results].
    Hesse G; Hoffmann H; Fricke H; Fleck WF
    Pharmazie; 1983 Nov; 38(11):740-3. PubMed ID: 6669594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Application of acetyl spiramycin to urinary tract infections].
    Shigematsu S; Okochi T; Noda S
    J Antibiot B; 1966 Aug; 19(4):297-304. PubMed ID: 4961327
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.